The Aesthetics Advisor

Up to 80% of patients experience prolonged illness after COVID-19. LHCS (Long Haul COVID Syndrome) is not only seen after the COVID infection but it is being observed in some people that have received vaccines.  According to a recent study of Mayo Clinic patients who had COVID-19, about 75% of the people suffering long COVID symptoms — defined as persistent symptoms even six months after recovery — are women. LHCS may persistent for months after the acute infection and almost half of patients report reduced quality of life. Patients may suffer prolonged neuropsychological symptoms, including multiple domains of cognition. ( Ref , Ref ) What are some common symptoms of post COVID syndrome? Their typical symptoms can include: Headaches Sleep difficulties Hair loss Smell disorder Decreased appetite Cognitive (ability to think) issues Erratic heartbeat  Chest pain Fatigue Gastrointestinal issues Intolerance to phys

Quercetin is an antioxidant that belongs to a class of water-soluble plant substances called  flavonoids , which are present in certain fruits and vegetables. It can be found in high quantities in tomatoes, red wine, onions, green tea, apples, berries, and Gingko Biloba. While the best way to get quercetin is through your diet, it also is available in supplement form, as pills or capsules. Sometimes, quercetin in supplement form is packaged with bromelain, an enzyme found in pineapples, because both have anti-inflammatory properties (Quercetin & Bromelain for inflammation). Most dietary supplements contain a chemical compound, aglycone, which is the free form of quercetin. Quercetin side effects are uncommon as this is considered to be one of the safest supplements you can take. However, Quercetin has a number of interactions, especially with certain medications like antibiotics and blood-thinning medicine. Quercetin Side Effects When taken by mouth: Quercetin is  POSSIBLY SAFE  fo

Nebulized hydroxychloroquine as 150 mg HCQ in 6 ml (25 mg/ml) of isotonic sterile solution within the first five (5) days of COVID-19 symptoms (“Nebu HCQ”) has resulted in immediate improvement (<1 hour after use) in breathing in COVID-19 infected patients. Nebu HCQ served as a rescue medication with an 80x improvement in time and efficiency when compared to HCQ tablet (400-600 mg per day) combination therapy or Ivermectin combination therapy. No adverse events were reported outside of a bitter taste that quickly subsided. The protocol used is as follows: 6 ml (25 mg HCQ per ml) per nebulizer session (15 minutes). Two sessions (12 ml total) in the first hour for patients with mild to moderate pulmonary symptoms from COVID-19. Since March 2020, my team has successfully treated over 3,000 patients with COVID-19 with the Zelenko Protocol . Our high-risk patient survival rate was >99.3% (0.7% mortality) which represents a radical improvement when compared to national data of high-ri

The Front Line COVID-19 Critical Care (FLCCC) Alliance was initially formed as a working group during the early COVID-19 pandemic days in response to multiple early reports of COVID patients with an inexplicably high need for prolonged mechanical ventilation and an excessive death rate. The FLCCC Alliance is steadily extending its network of physicians and other health professionals and health organizations who support their  I-MASK+ Prevention and Early Treatment Protocol and   MATH+ Hospital Treatment Protocol for COVID-19 ,  to help raise awareness and implementation of a treatment protocol that dramatically increases the life expectancy of critically ill COVID-19 patients. FLCCC strongly encourage interested medical professionals to read our   Scientific Review of COVID-19 and MATH+   and also to have a look into the Medical Evidence   and   The Research Challenge   pages. FLCCC Alliance core group Founding members / MATH+ and I-MASK+ developers Paul E. Mari